Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Shoulder Innovations, Inc.NYSE: SI
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses turns positive
Q1 FY2026 other income / expenses was $597K, compared with -$368K a year earlier. Trailing-twelve-month other income / expenses was -$13.1M.
Context
- Other income / expenses amounted to 29.7% of revenue in FY2025, up 26.7 pp from a year earlier.
- Other income / expenses grew in size in 1 of the last 2 fiscal years.
- FY2025 was the largest annual figure in the 3 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near $597K or moves back toward the trailing-twelve-month quarterly average of -$3.27M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (14.06M) USD
- Year-over-year change
- -1355.7%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (14.06M) | -1355.7% |
| FY2024 | 2024-12-31 | (966K) | +46.1% |
| FY2023 | 2023-12-31 | (1.79M) | — |
Other Income / Expenses vs competitors
How SI compares with its peers on the latest reported figures
- SI's LTM Mar 2026 other income / expenses of -$13.1M is the 9th highest of the 11 companies compared; the peer median is $3.8M.
- Its year-over-year change of -1224.3% is the lowest of 11, against a peer median of +14.6%.
- Other income / expenses amounts to 24.3% of revenue for SI, versus a peer median of 10.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $13.3M | +133.3% | — | 30.0% | |
| LTM Mar 2026 | $7.16M | +37.9% | +80.4% | 10.1% | |
| LTM Mar 2026 | $7.03M | -30.0% | +11.2% | — | |
| LTM Mar 2026 | $5.36M | -8.8% | +51.2% | 1.5% | |
| LTM Mar 2026 | $4.85M | +44.2% | — | — | |
EPRXEupraxia Pharmaceuticals Inc. | LTM Mar 2026 | $2.76M | +155.6% | — | — |
| LTM Mar 2026 | -$1.51M | -146.9% | +2.8% | 2.2% | |
| LTM Mar 2026 | -$7.09M | +65.4% | — | 6.0% | |
| LTM Mar 2026 | -$13.1M | -1224.3% | — | 24.3% | |
| LTM Dec 2025 | -$16.11M | -661.0% | — | 123.7% | |
| FY2025 | -$19.98M | -54.1% | — | 18.5% | |
| Peer median (excluding SI) | $3.8M | +14.6% | +31.2% | 10.1% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Revenue | 19.27M | 31.62M | 47.32M |
| Cost of Revenue | 4M | 7.28M | 11.12M |
| Gross Profit | 15.27M | 24.34M | 36.2M |
| Gross Margin | 79.2% | 77.0% | 76.5% |
| Research & Development | 3.02M | 4.49M | 7.73M |
| Selling, General & Admin | 23.11M | 34.51M | 54.77M |
| Operating Expenses | 26.13M | 38.99M | 62.5M |
| Depreciation & Amortization | 1.64M | 2.2M | 3.21M |
| EBITDA | (10.25M) | (12.11M) | (37.08M) |
| EBITDA Margin | -53.2% | -38.3% | -78.4% |
| Operating Income | (10.86M) | (14.65M) | (26.3M) |
| Operating Margin | -56.4% | -46.3% | -55.6% |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 761K | 1.32M | 70K |
| Other Income / Expenses | (1.79M) | (966K) | (14.06M) |
| Income Before Tax | (12.66M) | (15.62M) | (40.36M) |
| Pre-Tax Margin | -65.7% | -49.4% | -85.3% |
| Income Tax Expense | 0 | 0 | 0 |
| Net Income | (12.66M) | (15.62M) | (40.36M) |
| Net Margin | -65.7% | -49.4% | -85.3% |
| EPS (Basic) | (0.63) | (0.77) | (1.96) |
| EPS (Diluted) | (0.63) | (0.77) | (1.96) |
| Weighted Avg Shares | 19.92M | 19.92M | 20.63M |
| Weighted Avg Shares (Diluted) | 19.92M | 19.92M | 20.63M |
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.